Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 18 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 18, Issue 2 (June 2015) In this issue Reviews Original Articles Erratum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Reviews Top Re-purposing cryoablation: a combinatorial ‘therapy’ for the destruction of tissue J G Baust, J C Bischof, S Jiang-Hughes, T J Polascik, D B Rukstalis, A A Gage and J M Baust Prostate Cancer Prostatic Dis 2015 18: 87-95; advance online publication, January 27, 2015; 10.1038/pcan.2014.54 Abstract | Full Text A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers M E Schutzer, P F Orio, M C Biagioli, D A Asher, H Lomas and D Moghanaki Prostate Cancer Prostatic Dis 2015 18: 96-103; advance online publication, February 17, 2015; 10.1038/pcan.2015.4 Abstract | Full Text Original Articles Top Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system T J Daskivich, L Kwan, A Dash and M S Litwin Prostate Cancer Prostatic Dis 2015 18: 104-109; advance online publication, January 13, 2015; 10.1038/pcan.2014.51 Abstract | Full Text Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis A D Raval, D Thakker, A Vyas, M Salkini, S Madhavan and U Sambamoorthi Prostate Cancer Prostatic Dis 2015 18: 110-121; advance online publication, February 10, 2015; 10.1038/pcan.2014.52 Abstract | Full Text Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel H H Cheng, R Gulati, A Azad, R Nadal, P Twardowski, U N Vaishampayan, N Agarwal, E I Heath, S K Pal, H-t Rehman, A Leiter, J A Batten, R B Montgomery, M D Galsky, E S Antonarakis, K N Chi and E Y Yu Prostate Cancer Prostatic Dis 2015 18: 122-127; advance online publication, January 20, 2015; 10.1038/pcan.2014.53 Abstract | Full Text Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images M Abd-Alazeez, N Ramachandran, N Dikaios, H U Ahmed, M Emberton, A Kirkham, M Arya, S Taylor, S Halligan and S Punwani Prostate Cancer Prostatic Dis 2015 18: 128-136; advance online publication, February 3, 2015; 10.1038/pcan.2014.55 Abstract | Full Text Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer L-M Wong, D E Neal, A Finelli, S Davis, C Bonner, J Kapoor, J Trachtenberg, B Thomas, C M Hovens, A J Costello and N M Corcoran Prostate Cancer Prostatic Dis 2015 18: 137-143; advance online publication, February 10, 2015; 10.1038/pcan.2015.1 Abstract | Full Text Prospective evaluation of low-dose ketoconazole plus hydrocortisone in docetaxel pre-treated castration-resistant prostate cancer patients E N Lo, L A Beckett, C-X Pan, D Robles, J M Suga, J M Sands and P N Lara, Jr Prostate Cancer Prostatic Dis 2015 18: 144-148; advance online publication, February 10, 2015; 10.1038/pcan.2015.2 Abstract | Full Text Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project K C Cary, S Punnen, A Y Odisho, M S Litwin, C S Saigal, M R Cooperberg and and the NIDDK Urologic Diseases in America Project Prostate Cancer Prostatic Dis 2015 18: 149-154; advance online publication, February 10, 2015; 10.1038/pcan.2015.3 Abstract | Full Text Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer S Feuerlein, M S Davenport, A Krishnaraj, E M Merkle and R T Gupta Prostate Cancer Prostatic Dis 2015 18: 155-160; advance online publication, March 3, 2015; 10.1038/pcan.2015.5 Abstract | Full Text Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer J T Stover, R A Moore, K Davis, M R Harrison and A J Armstrong Prostate Cancer Prostatic Dis 2015 18: 161-166; advance online publication, March 17, 2015; 10.1038/pcan.2015.7 Abstract | Full Text Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09) M Joerger, R H N van Schaik, M L Becker, S Hayoz, M Pollak, R Cathomas, R Winterhalder, S Gillessen and C Rothermundt Prostate Cancer Prostatic Dis 2015 18: 167-172; advance online publication, March 10, 2015; 10.1038/pcan.2015.8 Abstract | Full Text Gonadotropin-releasing hormone agonist overuse: urologists’ response to reimbursement and characteristics associated with persistent overuse S D Ellis, M E Nielsen, W R Carpenter, G L Jackson, S B Wheeler, H Liu and M Weinberger Prostate Cancer Prostatic Dis 2015 18: 173-181; advance online publication, April 7, 2015; 10.1038/pcan.2015.10 Abstract | Full Text Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy J Cheng, R P Ondracek, D C Mehedint, K A Kasza, B Xu, S Gill, G Azabdaftari, S Yao, C D Morrison, J L Mohler and J R Marshall Prostate Cancer Prostatic Dis 2015 18: 182-189; advance online publication, April 14, 2015; 10.1038/pcan.2015.11 Abstract | Full Text Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort L C Macleod, L J Chery, E Y C Hu, S B Zeliadt, S K Holt, D W Lin, M P Porter, J L Gore and J L Wright Prostate Cancer Prostatic Dis 2015 18: 190-195; advance online publication, March 31, 2015; 10.1038/pcan.2015.12 Abstract | Full Text Erratum Top Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases P Cormie, R U Newton, N Spry, D Joseph, D R Taaffe and D A Galvão Prostate Cancer Prostatic Dis 2015 18: 196; 10.1038/pcan.2015.6 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.